Holy Basil (Tulsi)
Best-in-class: Holy Basil (Tulsi)
An adaptogenic herb for stress, mood and balanced cortisol, with bonus blood-sugar and immune support.
Holy Basil (Tulsi) quick facts
| Suggested dose | 300–600 mg extract daily. |
| How often | Daily |
| Who it's for | Everyday stress, mood and cortisol support. |
Covers cortisol and blood glucose simultaneously, which suits the 3am-wake pattern where nocturnal hypoglycemia and stress are both contributing. Trial evidence for anxiety and stress scores is reasonable. It has mild antiplatelet activity and can lower blood sugar meaningfully, so it matters alongside diabetes medication. Pleasant as a tea, which helps adherence.
How Holy Basil (Tulsi) actually works
Ocimum sanctum contains ursolic acid and eugenol, with demonstrated cortisol reduction and a separate glucose-lowering effect. The proposed mechanism for the anxiolytic action involves both COX-2 inhibition and modulation of the stress axis, though it is less precisely characterized than magnolia's receptor binding.
Where to get Holy Basil (Tulsi)
Find Holy Basil (Tulsi) on iHerb →The evidence for Holy Basil (Tulsi)
Graded by what exists behind each claim.
✅ Clinically validated
- RCTs show reduced stress/anxiety scores and improved mood.
- Also supports healthy blood sugar and immune function.
📊 Correlative data
- Central to Ayurvedic practice for well over two thousand years, where it is classed as a rasayana — a rejuvenative — and used specifically for stress rather than for a named disease. That framing survived into the modern trials, which is unusual and mildly reassuring about the tradition's observational accuracy.
- Populations in India with high habitual intake have not been shown to have different stress outcomes, so the traditional claim has never been tested epidemiologically.
🧪 Theoretical / extrapolated benefits
- A gentle daytime adaptogen — calming without sedation.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Holy Basil (Tulsi) actually does
Holy basil is Ocimum tenuiflorum (also written O. sanctum), and it has two chemically unrelated groups of actives that do two unrelated things. Confusing them is why most tulsi writing is vague.
Group one is eugenol, and it has the sharpest number in this entire cohort. Eugenol is the phenylpropene that gives clove and tulsi their smell, and it dominates the Ocimum tenuiflorum volatile oil. Tested against lipopolysaccharide-stimulated mouse macrophages, it inhibited prostaglandin E2 production with an IC50 of 0.37 micromolar and suppressed COX-2 messenger RNA but not COX-1 Kim 2003. That work isolated its eugenol from clove rather than from tulsi — the molecule is the same, the plant was not, and this page says so rather than implying the experiment was done on holy basil. Sub-micromolar potency with COX-2 selectivity at the transcript level is a serious pharmacological finding, and it is not what anybody selling a ‘gentle daytime adaptogen’ is describing.
And the enzymology underneath it is stranger than a simple inhibitor. Prostaglandin H synthase has two activities in one protein — a cyclooxygenase and a peroxidase — and eugenol is a phenolic peroxidase substrate. At low concentrations eugenol stimulates the enzyme; at higher concentrations it inhibits it, and the inhibition is highly dependent on arachidonic acid concentration because eugenol competes with arachidonate for the active site Thompson 1989. A biphasic dose–response with substrate competition means the direction of eugenol's effect depends on how much of it is present and how much arachidonate is around. That is a real mechanistic subtlety, and it predicts that a small dose and a large dose of the same plant do opposite things to the same enzyme.
Group two is the glycosides, and they are the ones with the stress data. Bioassay-guided work on Ocimum sanctum tested constituents at 40 mg/kg in rats against acute stress-induced biochemical changes: the lead compound normalized hyperglycemia, plasma corticosterone, plasma creatine kinase and adrenal hypertrophy, while two of the five compounds tested were ineffective Gupta 2007. Selectivity within a series is what separates a real active from an extract effect.
Those compounds were then named and tested against a chronic model. Ocimumoside A and ocimumoside B, at 40 mg/kg by mouth, reversed elevated plasma corticosterone back to control levels in a chronic unpredictable stress model, modulating brain monoamines and antioxidant systems, with efficacy similar to Panax quinquefolium at 100 mg/kg and melatonin at 20 mg/kg Ahmad 2012. A named molecule, an oral dose, a hormone returned to baseline, and two active comparators — that is the strongest preclinical stress result on any adaptogen page on this site.
So the honest mechanistic summary is two mechanisms in one leaf. A sub-micromolar COX-2-selective anti-inflammatory in the volatile oil Kim 2003 Thompson 1989, and a corticosterone-normalizing glycoside pair in the polar fraction Gupta 2007 Ahmad 2012. Which one is in your capsule depends entirely on how the leaf was extracted, and that is the form section.
Cell, rodent, human — and where it stops
Cells: human-relevant enzyme, real potency. PGE2 production inhibited at IC50 0.37 microM with COX-2 transcript suppressed and COX-1 spared Kim 2003; substrate competition at prostaglandin H synthase Thompson 1989.
Rodent: 40 mg/kg, oral, with corticosterone as the endpoint. Acute stress model Gupta 2007, then chronic unpredictable stress with plasma corticosterone returned to control Ahmad 2012. Both at 40 mg/kg of isolated compound — not of extract, and not of leaf.
Human, trial one: the largest placebo-controlled tulsi trial there is. One hundred and fifty people — 79 on placebo, 71 on the extract — took 1,200 mg of actives a day for six weeks. Stress symptoms fell significantly (P ≤ 0.05), with 39% more improvement in control of general stress symptoms than placebo, and the extract was described as effective and well tolerated Saxena 2012.
Human, trial two: smaller dose, harder endpoint, and a hormone measured. One hundred volunteers aged 18 to 65 took 125 mg twice daily for eight weeks. Perceived Stress Scale improved (p = 0.003), the Athens Insomnia Scale improved (p = 0.025), and — the part that matters — hair cortisol was lower (p = 0.025), with buffered stress responses on an acute laboratory stressor Lopresti 2022. Hair cortisol integrates exposure over months and cannot be faked by a good night's sleep before the visit. This is the single best piece of human evidence on the page.
Human, trial three: small, positive, and weak by design. Thirty-five people with generalized anxiety disorder, mean age 38.4, took 500 mg twice daily for 60 days, with significant attenuation of anxiety (p < 0.001) and improved attention Bhattacharyya 2008. Thirty-five people and no placebo arm is a pilot, and it should be read as one.
And the systematic review is the sentence that keeps this page honest. The review of clinical efficacy and safety of tulsi in humans found the studies uniformly favorable and uniformly limited — small, short, heterogeneous in preparation and dose Jamshidi 2017. Every trial above is positive. Every trial above is also under 160 people and under ten weeks.
So the specific obstacle is not translation, it is scale and specification. The rodent work is on isolated ocimumosides at 40 mg/kg Ahmad 2012; the human trials used three different commercial extracts at 250, 1,000 and 1,200 mg a day Lopresti 2022 Bhattacharyya 2008 Saxena 2012, none of which reports its ocimumoside or eugenol content. The doses differ almost five-fold and the materials are not comparable, so the trials cannot be pooled into a dose. The card's 300–600 mg sits between them and matches none of them exactly.
The second obstacle is what a stress trial can measure. Every endpoint above except hair cortisol Lopresti 2022 is a questionnaire, and questionnaires in unblinded or lightly blinded botanical trials move. The hair cortisol result is the one that survives that criticism, and it comes from a single trial of 100 people.
Holy Basil (Tulsi) — which form, and does it matter
The plant on the label may not be the plant in the capsule, and somebody checked. A genetic and phytochemical study of the commercial tulsi supply chain was published under the title ‘Product authenticity versus globalization — the Tulsi case’ Jurges 2018. Three Ocimum taxa are all sold as tulsi in India — Rama, Krishna and Vana — and Ocimum tenuiflorum is routinely confused with Ocimum gratissimum and with culinary basil, Ocimum basilicum. The existence of that study is the evidence: nobody haplotypes a supply chain that is not being substituted.
Extraction method decides which of the two mechanisms you bought, and this is the most actionable paragraph on the page. Eugenol is a volatile phenylpropene and reports to the essential oil or an alcoholic extract Kim 2003; the ocimumosides are polar glycosides and report to the aqueous or hydroalcoholic fraction Ahmad 2012. A steam-distilled tulsi oil is a eugenol product with no ocimumosides in it. A water extract is an ocimumoside product with little eugenol. Both are sold as ‘holy basil extract’, and the anti-inflammatory evidence and the stress evidence attach to different ones.
Which is why the branded extracts are worth naming. The two largest human trials used defined commercial extracts, at 1,200 mg of actives Saxena 2012 and 250 mg a day Lopresti 2022. Buying a named extract is buying the material a trial used. Buying ‘holy basil 500 mg’ is buying leaf powder of an unstated species, prepared by an unstated method.
What a label should carry. The species, in full, because three are sold under one name Jurges 2018. The extraction solvent, because it selects the mechanism. And a content figure for either eugenol or the ocimumosides — the only two constituent classes with a measured target Kim 2003 Ahmad 2012. No mass-market tulsi product states the third, and most do not state the second.
A note on eugenol dose that follows from the enzymology. Eugenol is biphasic at prostaglandin H synthase — stimulating at low concentrations, inhibiting at higher ones Thompson 1989. That is a formal reason not to assume a eugenol-rich tulsi oil is simply a milder version of a eugenol-poor extract. It may be doing the opposite thing at the same enzyme, and nobody has tested the two head to head in a person.
What would have to be true, and how you would know it was not
1. The Perceived Stress Scale, with the trial's own p-value rather than a promise. Score it before starting and at eight weeks. Predict a fall, because 125 mg twice daily for eight weeks improved it at p = 0.003 in 100 people Lopresti 2022 and 1,200 mg a day for six weeks produced 39% more improvement than placebo in 150 Saxena 2012. This is the endpoint most likely to move, and it is also the endpoint most vulnerable to expectation.
2. Hair cortisol, which is the measurement that cannot be talked into moving. A 3 cm segment of hair from the scalp integrates cortisol exposure over roughly three months. Predict it falls, because it did at p = 0.025 Lopresti 2022. This is the single most informative test on the page precisely because it is retrospective and physical: cut before starting, cut again at twelve weeks, and the second sample reports on the period you were taking it. Almost nobody does this and it is commercially available.
3. Morning serum cortisol — the prediction that cuts against the product. Predict no change. The rodent result was corticosterone normalized in stressed animals Ahmad 2012 Gupta 2007, not lowered in unstressed ones, and no human trial on this page reports a serum cortisol change. A single morning cortisol in a person whose axis is intact is a noisy measure of an already-normal quantity, and predicting that it stays put is both the honest expectation and a warning against the commonest self-experiment in this category.
4. Fasting glucose, because the rodent endpoint included it. The lead antistress compound normalized hyperglycemia alongside corticosterone Gupta 2007, and the card claims blood sugar support. Predict fasting glucose unchanged in a person with normal glucose, and treat any fall in somebody medicated for diabetes as an interaction rather than a benefit. Twelve weeks, with HbA1c alongside.
5. The prediction that would prove the eugenol mechanism reaches a person, and nobody has run it. Eugenol inhibits PGE2 production at an IC50 of 0.37 microM in cells Kim 2003. Urinary PGE-M, the major prostaglandin E2 metabolite, is a validated non-invasive index of systemic PGE2 production and is used routinely in chemoprevention research. Predict it falls on a eugenol-containing tulsi preparation and does not on an aqueous extract. That single comparison would settle which fraction is doing what, and it has never been done.
What nobody has tested yet
Nobody has measured an ocimumoside in a human. The compounds with the strongest preclinical stress data were dosed at 40 mg/kg in rats Ahmad 2012, and not one human trial reports the ocimumoside content of the extract it used Saxena 2012 Lopresti 2022 Bhattacharyya 2008. There is therefore no way to know whether the human trials delivered the molecules the rodent trials were about.
Nobody has compared the two fractions head to head. A eugenol-rich oil and an ocimumoside-rich aqueous extract are different pharmacologies from the same leaf Kim 2003 Ahmad 2012. A three-arm trial — oil, aqueous extract, placebo — with hair cortisol and a stress scale would tell buyers which product to buy, and it has never been run.
Nobody has tested the traditional claim epidemiologically. Tulsi has been a household plant across South Asia for two thousand years, which means there are populations with lifelong daily intake and populations without. No study has compared stress or cortisol outcomes between them, and the clinical review notes how small and short the entire human literature is Jamshidi 2017. It is the cheapest large study nobody has done.
And nobody has followed the fertility signal into a person. A benzene extract of Ocimum sanctum leaves at 250 mg/kg for 48 days reduced sperm count, motility and velocity, raised the proportion of abnormal sperm, and lowered fructose content in epididymal and seminal vesicle plasma — and the effects reversed within two weeks of stopping Ahmed 2002. Nobody has drawn a semen analysis in a man taking tulsi. It is a straightforward study, the rodent finding is 24 years old, and the population taking daily adaptogens overlaps heavily with the population trying to conceive.
Holy Basil (Tulsi) — its own safety story, not its category's
The fertility signal is this product's own, it is specific, and it has a dose and a time course. Rats given a benzene extract of Ocimum sanctum leaves at 250 mg/kg body weight for 48 days showed decreased sperm count, motility and velocity, an increased proportion of abnormal sperm, and decreased fructose in epididymal and seminal vesicle plasma — fructose being the energy substrate seminal vesicles supply to sperm. Everything reversed within two weeks of stopping Ahmed 2002. Note the qualifications: it is a rat, it is a benzene extract rather than a capsule, and 250 mg/kg is a large dose. Note also that it is reversible, which makes stopping a real option rather than a regret. Anyone trying to conceive should stop it, and should know that two weeks was enough in the animal.
The antiplatelet caution has an enzyme behind it, which changes how to weigh it. Eugenol acts at prostaglandin H synthase, competing with arachidonic acid for the active site Thompson 1989, and suppresses PGE2 production at sub-micromolar concentrations Kim 2003. Prostaglandin H synthase is the enzyme platelets use to make thromboxane. So the bleeding caution on tulsi is not a botanical courtesy: it is the same enzyme family aspirin acts on, in a plant whose oil can be rich in the active. That argues for stopping before surgery and for care alongside aspirin, clopidogrel or an anticoagulant.
Blood sugar, with the direction and the population that matters. The rodent antistress compound normalized hyperglycemia Gupta 2007 and the card claims blood-sugar support. In somebody on insulin, a sulfonylurea or a glinide, a glucose-lowering botanical is an additive risk of hypoglycemia rather than a benefit, and it is the interaction most likely to matter in practice. The clinical review reports tulsi as well tolerated across the human trials Jamshidi 2017, which is reassuring about the plant and says nothing about the combination.
The identity risk, stated as a practical rule. Three Ocimum taxa are sold as tulsi and the commercial supply chain has been shown to need authentication Jurges 2018. Buy a named species and a named extract; the trials used defined commercial materials Saxena 2012 Lopresti 2022, and a generic ‘holy basil’ capsule is not demonstrably the same plant.
And the honest closing balance. This is a well-tolerated herb with the best preclinical stress mechanism of anything in this cohort Ahmad 2012, one human trial with an objective hormone endpoint Lopresti 2022, and a total human evidence base of a few hundred people over a few weeks Jamshidi 2017. The risk is not that it hurts you. It is that it is sold with a confidence its evidence base does not support, and that the two genuinely consequential findings — the platelet enzyme and the reversible fertility effect — are the two nobody mentions.
Sources read for this page
- Kim SS, et al. Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Life Sciences 2003;73(3):337-348 · PMID 12757841
- Thompson D, Eling T. Mechanism of inhibition of prostaglandin H synthase by eugenol and other phenolic peroxidase substrates. Molecular Pharmacology 1989;36(5):809-817 · PMID 2511429
- Gupta P, et al. Constituents of Ocimum sanctum with antistress activity. Journal of Natural Products 2007;70(9):1410-1416 · PMID 17850106
- Ahmad A, et al. Novel Ocimumoside A and B as anti-stress agents: modulation of brain monoamines and antioxidant systems in chronic unpredictable stress model in rats. Phytomedicine 2012;19(7):639-647 · PMID 22455995
- Saxena RC, et al. Efficacy of an Extract of Ocimum tenuiflorum (OciBest) in the Management of General Stress: A Double-Blind, Placebo-Controlled Study. Evidence-Based Complementary and Alternative Medicine 2012;2012:894509 · PMID 21977056
- Lopresti AL, et al. A randomized, double-blind, placebo-controlled trial investigating the effects of an Ocimum tenuiflorum (Holy Basil) extract on stress, mood, and sleep in adults experiencing stress. Frontiers in Nutrition 2022;9:965130 · PMID 36185698
- Bhattacharyya D, et al. Controlled programmed trial of Ocimum sanctum leaf on generalized anxiety disorders. Nepal Medical College Journal 2008;10(3):176-179 · PMID 19253862
- Jamshidi N, Cohen MM. The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature. Evidence-Based Complementary and Alternative Medicine 2017;2017:9217567 · PMID 28400848
- Jurges G, et al. Product authenticity versus globalisation-The Tulsi case. PLoS One 2018;13(11):e0207763 · PMID 30475878
- Ahmed M, et al. Reversible anti-fertility effect of benzene extract of Ocimum sanctum leaves on sperm parameters and fructose content in rats. Journal of Basic and Clinical Physiology and Pharmacology 2002;13(1):51-59 · PMID 12099405
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Reactivity rather than mood: how long it takes you to come back down after something goes wrong, timed roughly in minutes. Tulsi is a mild daytime adaptogen and its trials moved stress and anxiety scores, so recovery from a spike is the fairest home version of that.
- How long before it means anything: Four to six weeks. Anything acting on the stress axis is slow, and the effect here is gentle enough that a single week will not separate the herb from the week.
- What will fool you: Its mildness. This is the quietest adaptogen on the shelf, so the noise of an ordinary life will bury it unless you are actually scoring something. Its blood-sugar arm is the other half worth knowing about — on glucose-lowering medication that interaction matters more than the stress read does.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Holy Basil (Tulsi) — safety & side effects
- Well tolerated; nausea on an empty stomach is the main report.
- Lowers blood sugar — additive with diabetes medication. Mild antiplatelet activity, so caution with anticoagulants and before surgery.
- Animal data suggest antifertility effects at high doses; avoid if trying to conceive, and in pregnancy.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Holy Basil (Tulsi) in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Holy Basil (Tulsi)
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| TSH (Thyroid-Stimulating Hormone) | Thyroid disease imitates every cognitive complaint there is |
| Vitamin B12 | Deficiency causes fog long before it causes anemia |
| Methylmalonic Acid (MMA) | Catches the deficiency a normal B12 hides |
| Ferritin | Low iron flattens cognition at levels most labs call fine |
| Vitamin D (25-Hydroxy) | Commonly low, cheap to correct, associated with mood |
The Brain Fog & Cognition panel covers these in one order — 12 markers, $233.06 with the discount applied.
Check results you already have → · All 103 markers A–Z
Holy Basil (Tulsi) — frequently asked questions
What is Holy Basil (Tulsi)?
An adaptogenic herb for stress, mood and balanced cortisol, with bonus blood-sugar and immune support.
What is the suggested dose of Holy Basil (Tulsi)?
300–600 mg extract daily. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Holy Basil (Tulsi) dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Holy Basil (Tulsi)?
Coach Cam sources Holy Basil (Tulsi) from vetted, top-rated brands on iHerb — use the buy link on this page.
Holy Basil (Tulsi) inside a finished plan
One arm of 2 Protocol Blueprints, free to read in full.
What Holy Basil (Tulsi) is used for
Holy Basil (Tulsi) appears under 3 goals in the goal router.
Related Cognitive & Mood supplements
Where this goes next
Holy Basil (Tulsi) is the upstream-cause arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.